In the Lancet Infectious Diseases, Eric Chow and colleagues1 present evidence of
remarkable population effectiveness against human papillomavirus (HPV), with virtual …

In the 20th century, a range of vaccines enabled major medical breakthroughs that helped to
prevent disease, protect public health, and reduce inequities in health care. Crucially, once …

In response to yearly increases in Escherichia coli bacteraemia, the UK Department of
Health recently launched mandatory E coli bacteraemia surveillance. 1 Before starting this …

Evidence is overwhelming to show that prophylactic human papillomavirus (HPV) vaccines
are very safe and highly efficacious in the prevention of HPV infections and related cervical …

In The Lancet Infectious Diseases, Talia Malagón and colleagues1 did a systematic review
and comparison of cross-protective efficacy induced by the two licensed human …

Inge Verdenius and colleagues1 suggest that cross-protection with the human
papillomavirus (HPV) vaccine Cervarix might prevent genotype replacement. Some points …

The discovery by Harald zur Hausen and colleagues about 30 years ago that cervical
cancer was caused by human papillomavirus (HPV) meant that the disease might be …

Comment www. thelancet. com/infection Vol 15 January 2015 9 and injection-drug users
were unsuccessful. 7 The failure of risk-based vaccination is one of several good reasons …

Human papillomaviruses (HPVs) are ancient stable DNA viruses that have coevolved for
millennia with their human hosts. 1 HPV types 6 and 11 are closely related papillomaviruses …

We read with interest the Article by Basil Donovan and colleagues, 1 who presented early
evidence of reduced morbidity of genital warts after the introduction of quadrivalent human …